Q-omics provides the consensus-scored RNU6ATAC26P profile across patient tissues and cancer cell-line models. RNU6ATAC26P expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, RNU6ATAC26P RNA expression shows 6,674 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight KIRC, and GBM as cancer lineages where RNU6ATAC26P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.